...
机译:艾地苯醌治疗腓特烈共济失调的疗效和安全性:早期结果和未来展望的审查
University of Pennsylvania School of Medicine, Departments of Neurology & Pediatrics and, The Children’s Hospital of Philadelphia, PA 19104, USA. University of Pennsylvania School of Medicine, Departments of Neurology & Pediatrics and, The Children’s Hospital of Philadelphia, PA 19104, USA.University of Pennsylvania School of Medicine, Department of Pathology & Laboratory Medicine, PA, USA. Children’s Hospital of Philadelphia, Department of Neurology, Abramson Research Center, Room 502, 3615 Civic Center Blvd, PA 19104, USA.;
antioxidant; Friedreich ataxia; hypertrophic cardiomyopathy; idebenone; international cooperative ataxia rating scale; mitochondrial dysfunction; neurodegeneration;
机译:艾地苯醌在小儿腓特烈共济失调患者中的神经学疗效评估:一项为期6个月的对照研究,然后为期12个月的开放标签延伸研究的数据
机译:艾地苯醌在小儿腓特烈共济失调患者中的神经学疗效评估:一项为期6个月的对照研究和一项为期12个月的开放标签延伸研究的数据
机译:介绍。艾地苯醌治疗腓特烈共济失调。
机译:多种抗革兰阴性感染治疗感染治疗感染的疗效和安全性:回顾性综述
机译:在Friedreich Ataxia的DNA甲基化
机译:Friedreich Ataxia的基因治疗的未来前景
机译:Friedreich共济失调:现状和未来展望